China Shineway Pharmaceutical Group Limited
HKEx Stock Code: 02877 Chinese
Our Business Products
Products
Modern Chinese Medicine
Industry Regulations
Growth Strategies

Dengzhanhuasu Injection

 
Function

To activate blood and eliminate blood stasis, to remove obstruction of channels to relieve pain. Used for treatment of coronary heart disease, angina pectoris and apoplexy sequela.

 
Main Materials

It is sterile solution of Breviscapine.

 
Specification

5ml each ampule: 20mg.

 
License No GuoYaoZhunZi Z13020778
 
Attention

Prohibit using in patients of cerebral hemorrhage or tendency of bleeding.

 
Usage & Dosage

Intramuscular injection, 5mg each time and 2 times daily;
Intravenous infusion, 10-20ml each time and one time daily, diluted with 500ml 10% glucose injection.

 
Storage Sealed and prevent from light.
 
Quality Guarantee 3 years
 
Back to Top